247 related articles for article (PubMed ID: 32698183)
1. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao P; Xia N; Zhang H; Deng T
Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and the risk of breast cancer in postmenopausal women.
Rosato V; Bosetti C; Talamini R; Levi F; Montella M; Giacosa A; Negri E; La Vecchia C
Ann Oncol; 2011 Dec; 22(12):2687-2692. PubMed ID: 21415236
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and outcomes following early-stage breast cancer.
Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
[TBL] [Abstract][Full Text] [Related]
5. Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis.
Zhong L; Liu J; Liu S; Tan G
Front Endocrinol (Lausanne); 2023; 14():1116582. PubMed ID: 37113491
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
Todowede OO; Mianda SZ; Sartorius B
Syst Rev; 2019 Jan; 8(1):4. PubMed ID: 30606249
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies.
Hallajzadeh J; Khoramdad M; Izadi N; Karamzad N; Almasi-Hashiani A; Ayubi E; Qorbani M; Pakzad R; Hasanzadeh A; Sullman MJM; Safiri S
Menopause; 2018 Oct; 25(10):1155-1164. PubMed ID: 29787477
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women.
Palmiero P; Maiello M; Cecere A; Ciccone MM
Acta Biomed; 2021 Sep; 92(4):e2021177. PubMed ID: 34487081
[TBL] [Abstract][Full Text] [Related]
11. Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.
Chen GC; Chen SJ; Zhang R; Hidayat K; Qin JB; Zhang YS; Qin LQ
Obes Rev; 2016 Nov; 17(11):1167-1177. PubMed ID: 27432212
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
13. Is Metabolic Syndrome Associated with the Risk of Recurrent Stroke: A Meta-Analysis of Cohort Studies.
Li X; Li X; Fang F; Fu X; Lin H; Gao Q
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2700-2705. PubMed ID: 29050848
[TBL] [Abstract][Full Text] [Related]
14. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
15. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
Dibaba DT; Ogunsina K; Braithwaite D; Akinyemiju T
Breast Cancer Res Treat; 2019 Feb; 174(1):209-218. PubMed ID: 30465158
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio, obesity, and breast cancer risk in Chinese population.
Fang Q; Tong YW; Wang G; Zhang N; Chen WG; Li YF; Shen KW; Wu BW; Chen XS
Medicine (Baltimore); 2018 Jul; 97(30):e11692. PubMed ID: 30045325
[TBL] [Abstract][Full Text] [Related]
18. Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study.
Choi IY; Chun S; Shin DW; Han K; Jeon KH; Yu J; Chae BJ; Suh M; Park YM
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803268
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and breast cancer risk: a systematic review and meta-analysis.
Han H; Guo W; Shi W; Yu Y; Zhang Y; Ye X; He J
Sci Rep; 2017 Mar; 7():44877. PubMed ID: 28317900
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women.
Kim BK; Chang Y; Ahn J; Jung HS; Kim CW; Yun KE; Kwon MJ; Suh BS; Chung EC; Shin H; Ryu S
Breast Cancer Res Treat; 2015 Sep; 153(2):425-34. PubMed ID: 26277917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
